Long-term Strattera seen OK for adults with ADHD

	Tweet

The non-stimulant treatment for attention-deficit/hyperactivity disorder, Strattera, is safe and effective when taken long-term by adults with the condition, according to interim study results.

The findings are based on 384 adults with attention-deficit/hyperactivity disorder (ADHD) treated with Strattera (generic name, atomoxetine) for up to 97 weeks, and who are participating in an ongoing study funded by drug-maker Eli Lilly and Company.

Treatment with atomoxetine produced significant improvement on all measures of ADHD symptoms, Dr. Lenard A. Adler from New York University and colleagues note in the Journal of Clinical Psychiatry.

Average total ADHD symptom scores on a standard adult scale fell 33 percent, from 29.2 to 19.5.

Atomoxetine led to improvement in functionality in work, family, and social areas of life, the researchers report, in line with results obtained in children.

Atomoxetine was generally well tolerated, the team says, noting that the pattern and frequency of side events with longer-term treatment were consistent with those observed during the earlier, 10-week studies.

These interim data “represent the longest systematic evaluation of any medication therapy in adult ADHD reported to date,” Adler and colleagues point out.

SOURCE: Journal of Clinical Psychiatry, March 2005.

RELATED STORIES:
Schizophrenia families not shielded from cancer   Early Neglect Predicts Aggressive Behavior in Children   Hormone replacement therapy tied to mental benefits   More than three-quarters of docs believe in God   Influencing Craving for Cigarettes by Stimulating the Brain   New study finds that violence doesn’t add to children’s enjoyment of TV shows, movies   Eye Divergence in Children Triples Risk of Mental Illness   Mom’s antidepressants tied to child health risks   Nicotine dependence remains prevalent despite recent declines in cigarette use   A new ally in the battle against cocaine addiction   Britons die later than they expect, save too little   Weeding out marijuana: Researchers close in on engineering recognizable, drug-free Cannabis plant

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]